Nova kolorimetrijska metoda određivanja indometacina pomoću 4-karboksil-2,6-dinitrobenzen diazonija by OLAJIRE AREMU ADEGOKE et al.
Indomethacin (INC), 1-(4-chlorobenzoyl)-5-methoxyl-2-methyl-1H-indole-3-acetic acid,
is an indole derivative with prominent anti-inflammatory and analgesic-antipyretic pro-
perties similar to those of salicylates (1). The anti-inflammatory effects of indomethacin
are evident in patients with rheumatoid and other types of arthritis, including acute gout.
There is evidence of both a central and a peripheral action (2). INC is a potent inhibitor
of cyclooxygenases, reducing prostaglandin synthesis, relieving pain and reducing fever
in febrile patients.
Some analytical methods have been reported for assaying INC in pure as well as in
pharmaceutical dosage forms. The methods include: densitometry (3), LC-MS (4), phos-
phorimetric method (5), polarography (6), spectrophotometric methods using Ehrlich’s
reagent (7), m-aminophenol-chloramine-T (8), 2-nitrophenylhydrazine (9), dimethylcin-
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A simple, sensitive and direct colorimetric method for the
determination of indomethacin either in pure form or in
capsules has been developed. The method is based on the
diazo coupling reaction between indomethacin and a high-
ly reactive arenediazonium ion, 4-carboxyl-2,6-dinitroben-
zene diazonium ion, with the consequent formation of an
azo dye. The reaction is fast and gave an orange azo dye
in ethyl acetate. The assay was carried out at 470 nm and
the azo adduct was stable for three hours. Beer’s law is
obeyed in the concentration range of 3.3–11 µg mL–1 of
indomethacin. Optimization studies established an opti-
mum reaction time of 20 minutes at 30 °C and the drug-
-to-reagent ratio of 1:2 for optimal detector response. The
method developed has a low limit of detection of 0.90 µg
mL–1 and is precise (RSD 2.3%). The new method has been
successfully applied to the determination of indometha-
cin in capsules and the method is of equivalent accuracy
as the official (BP) spectrophotometric method. The new
method could find application as a simple analytical me-
thod for the assay of indomethacin in capsules.
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namaldehyde in H2SO4 (10), NaNO2 in H2SO4 (11) and diazotized p-phenylenediamine
dihydrochloride (12). The official (BP) method (13) for the indomethacin pure form is ti-
tration in acetone using NaOH, while the capsules and suppositories are assayed by a
UV-VIS spectrophotometric method. Many of the methods already described for the as-
say of indomethacin suffer from the need of heating, or extensive extraction, or require
prior hydrolysis. All of these compromised accuracy and gave a higher Beer’s law range.
We recently described the sensitive, simple and accurate determination of mefenamic
acid capsules (14) and propranolol tablets (15) by colorimetry. The assay method employed
a derivatization procedure (aromatic ring derivatization technique) using the newly devel-
oped diazotized 4-amino-3,5-dinitrobenzoic acid (16, 17) and 4-carboxyl-2,6-dinitrobenzene
diazonium ion, CDNBD (18), as a chromogenic derivatizing reagent. In this paper, we de-
scribe the colorimetric assay of indomethacin via its azo adduct with CDNBD.
EXPERIMENTAL
Chemicals and reagents
Indomethacin capsule brands investigated are (A) Vital Vitacid® (Mission Pharma-
ceuticals ltd, Mumbai, India), (B) IndoRich (Richy Gold International, Hamburg, Ger-
many), (C) Flam (Formulations Plc Surrey, England), (D) Globa (Globa Pharmaceuticals
GMBH, Germany), (E) Indocid (Maxheal Pharmaceutical India), all containing 25 mg of
indomethacin per capsule. Indomethacin CRS (control No. 178078, WHO, Sweden), and
ethanol, ethyl acetate, glacial acetic acid, concentrated sulfuric acid, sodium nitrite (all
are analytical reagents from BDH, UK), pre-coated thin layer chromatographic plates
GF254, 0.2 mm (Merck, Germany) were used.
Equipment
UV/visible spectrophotometer (Unicam Aurora, Helio Scan software v 1.1, Pye Uni-
cam, UK), digital colorimeter (6051, Spectronic Analytical Instruments, Gathforth, UK),
ultrasonic bath (Langford Electronics Ltd, UK), nuclear magnetic resonance spectrometer
(AMX 400 Bruker Daltonik, Germany), FTIR (Ati-Mattson Genesis Series FTIR, Mattson
Instruments, USA), and mass spectrometer (FINNIGAN LCQMS, Thermo Electron Co.,
USA) were used.
Solutions and methods
The solution of CDNBD (0.918 mmol L–1), was prepared in concentrated sulfuric
acid (18).
Indomethacin stock solution (0.1%, m/m) was made by dissolving indomethacin
CRS in glacial acetic acid.
Optimization studies. – Two critical response parameters (temperature and reaction
time) were optimized using the method of steepest ascent. Aliquot (100 µL) of indome-
thacin stock solution containing 100 µg (2.8 mmol) of indomethacin was added to the re-
agent solution (500 µL, 459 mmol) in a test tube and the reaction mixture was mixed in a
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Vortex mixer for 10 s, followed by incubation at 30 °C and 50 °C for 5 minutes and 20
minutes, respectively. Similar experiments were performed at 60 °C and 80 °C. Each de-
termination was done in duplicate. The reaction was terminated by addition of ice-cold
water (5 mL) to the reaction mixture kept in an ice-bath. Aqueous solution was extracted
with ethyl acetate (10 mL) and kept in a vial wrapped with aluminum foil. A blank re-
agent solution was prepared in a similar way, but replacing the stock solution of indo-
methacin with glacial acetic acid. The absorption spectrum of the reaction mixture ex-
tract was determined against the absorption spectrum of the blank reagent extract, using
the UV-Vis spectrophotometer, and the optimal absorption wavelength, 470 nm, was se-
lected for sample determination on a digital colorimeter.
The optimal reaction time was determined by adding an aliquot of indomethacin
stock solution (100 µg, 2.8 mmol) to the reagent solution (500 µL, 459 mmol) in seven
tubes. Coupling reaction was carried out by incubation at 30 °C for 0, 5, 10, 15, 20, 25
and 30 minutes. Ethyl acetate extracts of the reaction mixture were prepared as usual af-
ter each reaction time and the absorbance was measured at 470 nm on the colorimeter.
The optimal reaction time was then determined as the time corresponding to the maxi-
mal absorption of the samples. All determinations were done in duplicate.
Stoichiometric ratio of drug-reagent. – Solutions of equivalent molarities (0.918 mmol L–1
CDNBD and 0.92 mmol L–1 of indomethacin) were used. Into six different test tubes, 0,
0.25, 0.5, 0.67, 0.75, and 1.0 mL of the reagent solution were added, respectively. Each tube
was then made up to 1.0 mL with the drug stock solution. A series of blank determina-
tions were carried out in which the volume of the drug stock solution was replaced with
glacial acetic acid. The mixture was mixed in a Vortex mixer for 10 s and kept at 30 °C for
20 minutes; extraction was carried out afterwards as usual. The absorbance was measured
at 470 nm against the blank and the absorbance values obtained were plotted against the
mole fraction of the reagent solution. Each determination was carried out in duplicate.
Stability of the azo adduct in ethyl acetate. – Standard test solutions containing 6.6 µg
mL–1 (0.02 mmol L–1) indomethacin were prepared in six sample vials. Three of the vials
were wrapped with aluminum foil, while the other three were left unwrapped. Both sets
were kept on the laboratory bench. The absorbance readings of the extracts at 470 nm
were taken at 30 min intervals for a period of three hours.
TLC analysis of azo adduct. – Standard test solution containing 6.6 ìg mL–1 (0.02 mmol
L–1) indomethacin was prepared as usual. The test solution containing the drug/reagent
azo adduct was spotted on a precoated thin layer chromatography plate (5 x 10 cm). The
reference sample of indomethacin was spotted alongside on the same plate and the blank
reagent. The plates were developed separately in three different mobile phases/ethyl ac-
etate/methanol, 9:1 (system I), chloroform/methanol, 8:2 (system II) and methanol/am-
monia, 100:1.5 (system III), visualized under UV lamp at 254 nm, and the Rf values were
computed.
Assay of CRS and dosage forms. – Preliminary INC identification was carried out by
comparing Rf values of INC CRS with each capsule formulation using the TLC system I.
The BP NaOH test (13) was also carried out.
The capsule content containing 3.3 mg of indomethacin was weighed, dissolved in
glacial acetic acid (6 mL) and mixed in an ultrasonicator for 5 min. The solution was fil-
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tered through a cotton wool plug into a 10-mL volumetric flask. The cotton wool plug
was rinsed with fresh glacial acetic into the flask and then made up with fresh glacial
acetic acid, rinsing the filter aid in the process. An aliquot of the drug stock solution (100
µg, 2.8 mmol) was added to the reagent solution (500 µL, 459 mmol). The mixture was
mixed in a Vortex mixer for 10 s and kept at 30 °C for 20 min; afterwards it was extracted
with ethyl acetate (5 mL) as described above. Absorbance was measured at 470 nm. De-
termination of the indomethacin content in capsules was done upon the calibration line.
The sample analysis was repeated using the BP procedure (13). Five formulations of in-
domethacin were used in the assays.
The assay results obtained by two methods were compared using the Student’s t-test
and F-ratio test. The 2-tailed probability values less than or equal to 0.05 were consid-
ered to be significant. Confidence interval was also determined for the result of the as-
say using the CDNBD method.
Figures of merit. – Calibration line was established upon 3 replicates. The assay pre-
cision was determined by a three-day precision assessment of reference INC recoveries
as prescribed by USP (19). Two approaches were adopted for accuracy. The % recoveries
of reference INC (3.3, 6.6 and 9.9 µg mL–1) were calculated based on a three-day assess-
ment. The second approach involved spiking 3.3 µg mL–1 (0.009 mmol L–1) of reference
INC into capsule formulations and determining % recoveries. The limit of detection (LOD)
was computed as the analyte concentration giving a signal equal to the blank signal plus
three standard deviations of the blank (20), while the limit of quantitation was comput-
ed as 3xLOD.
Two approaches were adopted for investigating the method selectivity. In the fist ap-
proach, aliquots of the stock solution (containing 6.6 µg mL–1, 0.02 mmol L–1) were spiked
into each of lactose, magnesium stearate, starch as well as a mixture of these three excipi-
ents, commonly used in capsule formulation. Recoveries of indomethacin were determined
using 500 µL (459 mmol) of the reagent and carrying out the procedure as usual.
In the second approach, samples of the five brands and the primary reference sub-
stance were kept at 100 °C in the oven for 5 hours. Afterwards, the methanolic extract of
the samples and the reference substance were analyzed for possible degradation pro-
ducts. Three separate chromatographic systems were employed, as described earlier.
Synthesis, purification and characterization of azo adduct. – The CDNBD reagent (0.918
mmol L–1) was prepared in concentrated sulfuric acid as reported previously (18). For
each batch, 15 mg of indomethacin (reference substance) was weighed and dissolved in 10
mL glacial acetic acid. The solution was poured into the reagent solution and stirred con-
tinuously for 3 hours. At the end of the period, the reaction mixture was poured into ice
cubes and allowed to separate overnight. The reddish-brown azo dye was recovered by
filtration and dried at 70 °C. Several batches were similarly prepared and pooled together.
The crude indomethacin derived dye was purified by column chromatography us-
ing silica gel of flash chromatography grade (particle size 0.040–0.063 mm) by gradient
elution. The crude product was dissolved in methanol, concentrated on a water-bath
and then adsorbed on silica gel, and dried in the oven. Silica gel 60 (10 g) (Merck, Ger-
many) was dispersed in n-hexane. The slurry was poured into the column and allowed
to settle. Filter paper disc was dropped on the surface. The column was deaerated by
positive pressure. The sample of indomethacin adduct adsorbed on silica gel was pour-
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ed into the column containing a head of n-hexane. The column was packed under posi-
tive pressure. Gradient elution was carried out using hexane, ethyl acetate and methanol
(from 100% hexane to 100% ethyl acetate to 100% methanol, with sucessive 10% addition
of the next polar solvent until the final elution with 100% methanol). Column fractions
were collected and spotted on a TLC plate developed in EtOAc:MeOH (9:1). The major
fraction was the reddish-brown azo dye eluted by hexane/EtOAc (20:80) and this was
collected and dried using the rotary evaporator. The dried sample was reconstituted in
methanol and allowed to dry in a vacuum oven.
The 1H NMR of the indomethacin azo adduct (Fig. 3, Table IV) was carried out in
deuterated pyridine solution. Field strength of 400.14 MHz with 128 scans was applied.
All chemical shift values were referred to the 8.68 signal of pyridine. The IR spectra of
indomethacin (Fig. 2) and the azo adduct were recorded in KBr disk using the GENESIS
FTIR machine fitted with WINFIRST® software for data acquisition and processing. Ne-
gative electrospray ionization technique (ESI) mass spectrometry was used for the analy-
sis of the azo adduct.
RESULTS AND DISCUSSION
Diazo coupling reaction between the reagent and INC gave an instant purple colour
indicating the formation of an azo dye (Scheme 1). The ethyl acetate extract of the ad-
duct, however, is orange in colour. The absorption spectra of INC in ethyl acetate showed
two maxima at 290 and 320 nm, and optimal absorbance when compared with the re-
agent was found at 470 nm. CDNBD exhibits absorption maxima at 260, 340 and 430 nm.
The spectra of INC, CDNBD and the azo adduct are presented in Fig. 1. The absorption
spectrum of the azo adduct shows a bathochromic shift with respect to INC while a hyp-
erchromic shift was observed when compared with blank reagent. The peak at 470 nm
was selected as the analytical wavelength, because at this wavelength the difference in
absorptivity between the blank reagent and the adduct is maximal (21). Optimization
studies revealed maximum absorbance of the adduct at 30 °C after 20 minutes reaction
time. Incubation at elevated temperatures (higher than 30 °C) led to thermal degrada-
tion and lower detector response. The azo adduct formed by the coupling reaction was
stable to light in the laboratory environment over a period of 3 h (6.3 µg mL–1 was esti-
mated for the analyte through a three hour period). Thin layer chromatographic analy-
ses of the azo adduct in three mobile phase systems are presented in Table II, alongside
those of capsules that were kept at elevated temperature for 5 hours.
Indomethacin is a methoxyl indole. Diazo coupling reaction fails between prototype
arenediazonium ions and phenol ethers. Exceptionally reactive diazonium ion like 2,4-di-
nitrobenzenediazonium ion, was however reported to couple with some phenol ethers
(anisole and phenetole), although it was not applied as a reagent (22). The instant colour
obtained by reacting INC with CDNBD underscores the exceptional reactivity of this dia-
zonium ion. CDNBD is also a dinitrobenzene diazonium analog. The stoichiometric ra-
tio for the reagent and INC was the mole ratio of 2:1. The implication is that combining
twice the molar concentration of the reagent with that of INC will produce the highest
possible absorbance reading (23).
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The spectroscopic characterization of the azo adduct was done using IR, 1H NMR
and MS. IR spectrum of INC (Fig. 2a) and that of the azo adduct (Fig. 2b) showed differ-
ences at the following frequencies (cm–1): 1700.62 (s) due to C=Ostr (CDNBD residue),
1550 (s) due to aromatic N…Ostr and 3428 (b) due to free phenolic OHstr, all present in
the adduct and absent in INC. Absence of the band at 1235 (s) due to alkyl-aryl ether
suggests the likely cleavage of the linkage on coupling. The proton NMR is presented in
Fig. 3. One feature of the proton NMR recorded for the indomethacin adduct is the pres-
ence of solvent residues mainly n-hexane and ethyl acetate, which produced some com-
plexities in the signals. However, a prominent observation is the complete disappear-
ance of the signal due to methoxyl protons. The assigned signals (ä, ppm) are shown in
194











































Table IV. The assigned signals seem to reveal that indomethacin may have used up two
moles of the reagent, as observed for the stoichiometric ratio assessment. The protons on
the CDNBD residue were found at 9.34 as strongly intense singlets with an integral gre-
ater than 2, implying the presence of up to 3 or more protons (24). The 6th position on
the indomethacin molecule appeared to be most favoured for the coupling with the first
molecule of CDNBD since it is the most shielded. This, therefore, transforms the triplet
on C-4 and doublet on C-7 to singlets, one of which may likely be the singlet occurring
at 9.12 ppm. This can actually be H-7 since it will experience strong deshielding influ-
ence of the azo linkage and amide linkage. The second singlet however could not be as-
signed with such accuracy but could be either of 8.31 or 8.33 ppm. The singlet occurring
at 9.23 ppm with integral an of about three protons may be due to H-5´ and H-6´. Either
of C-3´ or C-5´ on the indomethacin may have been favoured since both protons are meta
to a carbonyl group, and ortho to the chlorine on C-4´. C-3´ will most likely be preferred
due to steric considerations. The C-2´ proton could also be either of the singlets occur-
ring at 8.31 and 8.33 ppm. The fact that two moles of CDNBD can be substituted in the
indomethacin molecule can be attributed to the isolated nature of the rings, which may
permit simultaneous electrophilic attack. The mass spectrum of the indomethacin ad-
duct is presented in Fig. 4. Even though no molecular ion corresponding to the proposed
adduct in Scheme 1 was obtained, an ion with an m/z of 581.50 is present, which corre-
sponds to a 1:1 reaction product between indomethacin and CDNBD. This therefore im-
plies that the expected molecular ion of 820.30 (corresponding to 1:2 mole ratio) is not
stable during ionization and could not be detected. Other fragments in the mass spec-
trum are m/z (% relative abundance): 549.83 (100%), 445.28 (26.42%), 367.38 (28.30%), 337.23
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Fig. 1. Absorption spectra of indomethacin (__) (10 ìg
mL–1 INC, 28 mmol L–1 INC), indomethacin-CDNBD
azo adduct (- - -) (28 mmol L–1 INC, 459 mmol CDNBD)
and CDNBD (----) in ethyl acetate.
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Fig. 2. IR spectra of: a) indomethacin and b) indomethacin-CDNBD azo adduct.
a)
b)
(71.70%), 320.12 (69.81%) and 226.36 (14.91%), which is the molecular mass of 4-amino-
-3,5-dinitrobenzoic acid (ADBA), a precursor of the CDNBD molecule.
The regression equation for the calibration curve under the optimal conditions used
for the assay is y = (0.0187 ± 0.0018) · ã + (0.102 ± 0.011) (95% confidence limits, R2 =
0.9974, ã in µg mL–1). The large intercept obtained for the calibration curve can be attrib-
uted to the hyperchromic shift of the absorption maximum of the azo adduct compared
to the reagent. The limit of detection was determined as 0.90 µg mL–1 with an LOQ of
2.7 µg mL–1. The overall recovery of extracted samples is 96.9 ± 2.2% and of RSD 2.3 %
(n = 27). The highest negative bias observed for 3.3 µg mL–1 IND on day 1 might be due
to extraction error. Accuracy assessment, done by spiking INC reference into dosage
forms and analyzing the mixture showed similar results when compared to the analysis
of capsules alone.
In the selectivity assessment of the new method, the percentage recovery obtained
by the use of 6.6 µg mL–1 analyte size was 99.6 ± 2.4%. The following recoveries of INC
adduct were obtained in the presence of tablet excipients: 99.7 ± 2.6% (lactose), 99.6 ± 2.4%
(starch), 99.7 ± 2.6% (magnesium stearate) and 99.7 ± 2.7% (mixture of excipients, n = 4
in all cases). The closeness of recoveries suggests a lack of interference from tablet ex-
cipients and thereby establishing some degree of method selectivity. In the second ap-
proach, the TLC analysis reveals no degradation product in the capsules stored at ele-
vated temperatures (Table II).
197
O. A. Adegoke et al.: Novel colorimetric assay of indomethacin using 4-carboxyl-2,6-dinitrobenzene diazonium ion, Acta Pharm. 56
(2006) 189–202.
Fig. 3. 1H NMR spectrum of indomethacin in pyridine-d5.
All the brands of indomethacin capsules assayed were found to contain INC using
the TLC procedure described above and the BP (13) NaOH test. Comparative analysis of
the five brands of indomethacin capsules by the official spectroscopic method (13) and
the new colorimetric method is shown in Table III. There is no significant difference be-
tween the accuracy of both methods. The active ingredient content ranged between 92.45
and 102.12% of the declared value. The BP requires that indomethacin capsule should
contain between 90 and 110% of indomethacin.
While the advantage of simplicity of this new method is self-evident, the method
also provides a novel procedure for the assay of indomethacin capsules. The initial pur-
ple colour produced when a solution of indomethacin in glacial acetic acid reacts with
the reagent and the eventual orange colour in ethyl acetate could serve as additional
qualitative tests for the capsules.
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Table I. Inter-day accuracy and precision of the indomethacin assay
INC
(µg mL–1)a















3.3 96.5 ± 4.7 4.9 93.8 ± 0.0 0.0 93.8 ± 0.0 0.0 94.7 ± 1.3 1.4
6.6 96.6 ± 2.0 2.1 98.7 ± 3.9 3.9 99.7 ± 4.7 4.7 99.7 ± 1.3 1.3
9.9 99 ± 3.1 3.2 95.6 ± 1.4 1.4 98.3 ± 4.1 4.1 98.3 ± 1.8 1.8
a n = 9 at each concentration level. Regression equation: y = 0.0187ã + 0.102 (R2 = 0.9974).
Between-day statistics for all concentrations: 96.86 ± 2.20% (RSD = 2.3%).
Fig. 4. Mass spectrum of indomethacin-CDNBD azo adduct (negative ESI).
The new method gives comparable reproducibility to the use of m-aminophenol-
-chloramine-T and resorcinol-sodium hypochlorite by Sastry et al. (8). However, the pro-
cedure of Abdel-Hay et al. (9) required the use of dicyclohexylcarbodiimide as a conden-
sation catalyst for hydrazide formation with 2-nitrophenylhydrazine. Similarly, the use
of 4-dimethylaminocinnamaldehyde in H2SO4 requires propan-2-ol to stabilize the colour
(10). Both methods work in a calibration range higher than for CDNBD method reported
here, thereby conferring the advantage of sensitivity to the latter. Since other carboxylic
acid-containing substances and indole nucleus may react, respectively, in the two meth-
ods, the selectivity will obviously be affected. The use of nitrosyl sulphuric acid as de-
scribed by Chowdary et al. (11) has the main disadvantage of cross reaction with any
other aromatic nucleus, which may be present since it is not a specific reaction. The con-
centration range of 25–150 ìg mL–1 used is almost 80–120% that of the CDNBD new
method. A procedure based on diazo-coupling reaction was, however, recently reported
by Nagaraja et al. (12). The method, which involves an initial hydrolysis of INC before
diazo coupling is effected with p-phenylenediamine dihydrochloride in sulphuric acid
medium. This hydrolytic step could compromise accuracy, especially when handled by
an inexperienced analyst. The utilization of CDNBD does not require heating, extensive
extraction or prior hydrolysis.
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Table II. Thin layer chromatographic analysis of indomethacin capsules and indomethacin/CDNBD





INC A B C D E
EtOAc : MeOH (9:1) 0.81 0.81 0.81 0.81 0.81 0.81 0.22 0.55
CHCl3 : MeOH (8:2) 0.82 0.82 0.82 0.82 0.82 0.82 0.55 0.87
MeOH : NH3 (100 :1.5)
a 0.85 0.85 0.85 0.85 0.85 0.85 0.65 0.59
a Plate was coated with 0.1 mol L–1 methanolic KOH before spotting the samples.





A 92.45 ± 0.71 95.56 ± 3.38 96.6 ± 1.3 6.5 ± 0.2
B 93.89 ± 0.58 95.62 ± 5.74 96.3 ± 2.9 6.4 ± 0.4
C 95.38 ± 0.95 98.87 ± 4.45 97.9 ± 2.4 6.5 ± 0.2
D 92.77 ± 0.30 94.00 ± 2.22 93.2 ± 1.8 6.2 ± 0.1
E 97.61 ± 0.21 102.12 ± 3.36 102.4 ± 1.6 6.7 ± 0.2
a n = 5. Capsule is expected to contain between 90 and 110% of declared drug amount (25 mg INC) (BP).
b Official spectrophotometric method.
c CDNBD – new colorimetric assay.
d Spiked with 3.3 ìg mL–1 (concentration assayed = 9.9 ìg mL–1).
e Confidence interval for 6.6 ìg mL–1 analyte at p = 0.05.
The CDNBD method, when compared with the official (BP) spectrophotometric me-
thod (13), is sensitive with low limits of detection. The new method does not require
strict control of pH unlike the official method that uses methanol/phosphate buffer pH
7.2 as solvent. Low analyte levels of INC can be also determined with sufficient accuracy
in the CDNBD method.
CONCLUSIONS
The CDNBD method described in this work is a simple, direct and sensitive colo-
rimetric assay procedure. The new method is of the same accuracy as the official (BP)
spectrophotometric assay. The advantages of the new method reported here are its sim-
plicity, more affordable instrumentation (digital colorimeter) and the lower analyte lev-
els compared to the BP method. It may find application in the in-process quality control
of indomethacin capsules.
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S A @ E T A K
Nova kolorimetrijska metoda odre|ivanja indometacina pomo}u
4-karboksil-2,6-dinitrobenzen diazonija
OLAJIRE AREMU ADEGOKE, OLAKUNLE SUNDAY IDOWU i AJIBOLA AKINYEMI OLANIYI
Razvijena je jednostavna, osjetljiva i izravna kolorimetrijska metoda za odre|ivanje
~istog indometacina i indometacina u kapsulama. Metoda se temelji na reakciji diazo ko-
pulacije izme|u indometacina i vrlo reaktivnog arendiazonijevog iona, diazonijevog iona
4-karboksil-2,6-dinitrobenzena, pri ~emu nastaje azo obojeni spoj. Reakcija je brza i daje
azo spoj naran~aste boje u etil-acetatu, koji je stabilan tri sata. Odre|ivanje se izvodi na
470 nm. Beerov zakon vrijedi u koncentracijskom podru~ju od 3,3 do 11 g mL–1. Na
temperaturi 30 °C optimalno vrijeme reakcije je 20 minuta, a optimalni omjer analita i
reagensa 1:2. Granica detekcije je niska (0,90 g mL–1), a metoda precizna (RSD 2,3%).
Metoda je uspje{no primijenjena i za odre|ivanje indometacina u kapsulama s jednakom
to~no{}u kao i oficijalna spektrofotometrijska metoda (BP).
Klju~ne rije~i: indometacin, kolorimetrija, 4-karboksil-2,6-dinitrobenzen diazonij, diazo kopulacija
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